Disease |
Disease |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
Source |
gastric adenocarcinoma |
GAC tissues and matched adjacent normal qRT-PCR |
gastric adenocarcinomas (GACs) |
up-regulated |
N/A |
Expression of NEAT1 lncRNA was enhanced in GACs and influence GAC progression by promoting tumor growth |
26911892 |
|
gastric cancer |
gastric cancer samples and cell lines by real-time PCR |
gastric cancer tissues and cell lines |
up-regulated |
N/A |
LncRNA NEAT1 was overexpressed in gastric cancer tissues and cell lines and corrected with clinical stage, histological type, lymph node metastasis, and distant metastasis |
27095450 |
|
paraspeckle disintegration |
Immunoprecipitation of Ribonucleoprotein Complex,knockdown |
HeLa cell |
down-regulated |
mutation |
Successful removal of MENepsilon/beta by a refined knockdown method resulted in paraspeckle disintegration. Furthermore, the reassembly of paraspeckles disassembled by transcriptional arrest appeared to be unsuccessful in the absence of MENepsilon/beta. |
19188602 |
|
ovarian cancer |
knockdown of NEAT1_1 |
OC patients and OVCAR-3 cell lines |
up-regulated |
N/A |
lncRNA NEAT1, whose expression was collaboratively controlled by HuR and miR-124-3p, could regulate ovarian carcinogenesis |
27075229 |
|
malignant pleural mesothelioma |
microarray, qPCR etc. |
MPM tissue, cell lines (H28, H226, H2052, H2452, MSTO etc.) |
up-regulated |
N/A |
AK130977 and AX746718 were both found to be down-regulated via both microarray and RT-qPCR (AK130977 Microarray (MA) = -5.207, RT-qPCR = -1.6; AX746718 MA = -3.37, RT-qPCR = -4.6), with AK130977 demonstrating fairly small changes using RT-qPCR. Similarly, BX648695, AK129685, EF177379, AK054908, AK130275, AF268386 and NR_003584 all demonstrated consistent up-regulation using both microarrays and RT-qPCR. |
23976967 |
Lnc2Cancer
|
papillary thyroid carcinoma |
microarray, qPCR etc. |
papillary thyroid carcinoma tissue |
up-regulated |
expression |
Expression profiles of five lnc-RNAs (MEG3, HULC, HOTAIR, NEAT1, and MALAT-1) previously shown to be involved in cancer metastasis were detected by qPCR in 5 pairs of papillary thyroid cancer and 11 matched lymph node metastatic tissues. Among the five, MEG3 showed significant down-expression. Overexpression of MEG3 inhibits thyroid cancer cell migration and invasion. |
25997963 |
Lnc2Cancer
|
prostate cancer |
microarray, RNA-seq, qPCR, Northern bolt, knockdown etc. |
prostate cancer tissue, cell lines (LNCaP, CWR22Rv1, PC3 etc.) |
up-regulated |
N/A |
Interestingly, nine out of these thirteen known cancer-related lncRNA showed significantly differential expression between tumor and normal prostate samples. Several lncRNA such as NEAT1, DANCR, HOTTIP, PRINS, and EGOT that have established functions in forming nuclear speckles, in development or in autoimmune disease, but were not previously known to be related to cancer, showed differential expression between tumor and normal prostate samples, suggesting their potential function in prostate cancer. |
23728290 |
Lnc2Cancer
|
nasopharyngeal carcinoma |
N/A |
NPC cell lines and tissues |
up-regulated |
N/A |
significantly upregulated in NPC cell lines and tissues |
27020592 |
|
frontotemporal lobar degeneration |
N/A |
N/A |
N/A |
Interaction |
Analysis of RNA binding by TDP-43 in brains from subjects with FTLD revealed that the greatest increases in binding were to the MALAT1 and NEAT-1 noncoding RNAs. |
20581224 |
LncRNADisease Lnc2Cancer
|
Huntington's disease |
N/A |
N/A |
N/A |
expression |
LncRNAs TUG1 (necessary for retinal development), and NEAT-1 (a structural component of nuclear paraspeckles) are upregulated in HD caudate, while the brain-specific tumor-suppressor MEG3 is downregulated in HD. |
23346095 |
LncRNADisease
|
AIDS |
N/A |
N/A |
N/A |
expression |
We found NEAT-1 to be one of several lncRNAs whose expression is changed by HIV-1 infection, and we have characterized its role in HIV-1 replication. |
23362321 |
LncRNADisease
|
amyotrophic lateral sclerosis |
N/A |
N/A |
N/A |
regulation |
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. |
23835137 |
LncRNADisease
|
intrauterine growth restriction |
N/A |
N/A |
N/A |
expression |
The long non-coding RNA NEAT-1 is increased in IUGR placentas, leading to potential new hypotheses of IUGR origin/development. |
24280234 |
LncRNADisease
|
oral squamous cell carcinoma |
N/A |
N/A |
N/A |
expression |
Subsequently, they confirmed that the expression levels of HOTAIR, NEAT-1 and UCA2 in metastasized samples was prominent higher than the non-metastatic samples.? |
24817925 |
LncRNADisease
|
oral squamous cell carcinoma |
qPCR etc. |
OSCC tissues |
up-regulated |
N/A |
We found that most of the selected transcripts (4/6) were upregulated in tumors relative to matched adjacent nonmalignant tissue. One gene, MEG-3, was downregulated in cancer compared with its adjacent nonmalignant tissue. Expression of lncRNA (HOTAIR, NEAT-1 and UCA1) was significantly higher in the samples that subsequently metastasized compared with the non-metastatic samples. By contrast, MEG-3 was downregulated in the metastatic samples. These findings suggest that the detection of lncRNAs in saliva may be used as a noninvasive and rapid diagnostic tool for the diagnosis of oral cancer. |
23292713 |
Lnc2Cancer
|
non-small cell lung cancer |
qPCR etc. |
lung cancer tissue |
up-regulated |
expression |
The relative level of NEAT1 in NSCLC tissues was significantly elevated as compared to that of the adjacent non-cancer lung tissues. NEAT1 expression was positively correlated with patient age, lymphatic metastasis, vascular invasion and clinical TNM stage. lncRNA NEAT1 may act as a oncogene, which plays an important role in the tumorigenesis and deterioration of human NSCLC. |
25854373 |
Lnc2Cancer
|
hepatocelluar carcinoma |
qPCR etc. |
HCC tissue |
up-regulated |
interaction |
Our results revealed that NEAT1 appeared to have higher expression in the HCC tissues, compared with the adjacent non-cancerous liver tissues. High levels of NEAT1 promoted the clinical features of HCC, including the number of tumor nodes, metastasis, clinical TNM stage, the status of portal vein tumor embolus, vaso-invasion and the infiltration of tumor cells. Additionally, high NEAT1 expression levels were significantly associated with the expression level of MDTH, NM23 and MALAT1 |
26191242 |
Lnc2Cancer
|
colorectal cancer |
qPCR etc. |
CRC tissue |
up-regulated |
expression |
Results showed that NEAT1 expression in colorectal cancer was up-regulated in 72.0% (172/239) cases compared with corresponding normal counterparts, and related to tumor differentiation, invasion, metastasis and TNM stage. |
26314847 |
Lnc2Cancer
|
glioma |
qPCR etc. |
glioma tissue |
up-regulated |
expression |
In our results, the relative level of NEAT1 expression was higher in cancer tissues compared with adjacent noncancerous tissues (p < 0.001). High NEAT1 expression was observed to be closely correlated with larger tumor size (p = 0.023), higher WHO grade (p = 0.005), and recurrence (p = 0.011). |
26582084 |
Lnc2Cancer
|
breast cancer |
qPCR, ISH etc. |
cell lines (MCF-7, MDA-MB-231, MDAMB-468) |
up-regulated |
expression |
Induction of NEAT1 in hypoxia also leads to accelerated cellular proliferation, improved clonogenic survival and reduced apoptosis, all of which are hallmarks of increased tumorigenesis. Furthermore, in patients with breast cancer, high tumor NEAT1 expression correlates with poor survival, all of which are hallmarks of increased tumorigenesis. |
25417700 |
Lnc2Cancer
|
esophageal squamous cell carcinoma |
qPCR, knockdown etc. |
ESCC tissue, cell lines (SHEE, SHEEC) |
up-regulated |
expression |
We found that the expression of NEAT1 was higher in ESCC tissues and cells compared with the normal counterparts. Pearson analysis showed that elevated NEAT1 levels were extraordinarily correlated with the tumor size (P=0.026), lymph node metastasis (P=0.035) and clinical stage (P=0.004). |
26609486 |
Lnc2Cancer
|
acute promyelocytic leukemia |
qPCR, Western blot etc. |
blood, cell lines (NB4, NB4-R2, U937-PR9) |
down-regulated |
expression |
We found that NEAT1 is significantly repressed in de novo APL samples compared with those of healthy donors. We further provide evidence that NEAT1 expression was repressed by PML-RAR抅 Furthermore, significant NEAT1 upregulation was observed during all-trans retinoic acid (ATRA)-induced NB4 cell differentiation. |
25245097 |
Lnc2Cancer
|
Burkitt's lymphoma |
qPCR, Western blot, knockdown etc. |
blood |
up-regulated |
interaction |
NEAT1 expression levels were validated by qPCR, demonstrating high baseline expression (average Cp = 21.3), and confirming p53-dependent induction . lncRNAs NEAT1 and lincRNA-p21 as novel elements of the p53-dependent DNA damage response machinery in CLL and lymphoma. |
25971364 |
Lnc2Cancer
|
chronic lymphocytic leukemia |
qPCR, Western blot, knockdown etc. |
blood |
up-regulated |
expression |
NEAT1 expression levels were validated by qPCR, demonstrating high baseline expression (average Cp = 21.3), and confirming p53-dependent induction .lncRNAs NEAT1 and lincRNA-p21 as novel elements of the p53-dependent DNA damage response machinery in CLL and lymphoma. |
25971364 |
Lnc2Cancer
|
lung cancer |
qRT-PCR |
lung carcinoma cell lines |
N/A |
expression |
Our data indicate that miR-449a may function as a suppressor of lung cancer, and affects the expression of NEAT1 in lung cancer cells. |
25818739 |
|
non-small-cell lung cancer |
qRT-PCR |
patients suffering from non-small-cell lung cancer (NSCLC) |
up-regulated |
expression |
N/A |
26448925 |
|
obesity |
reexpression |
adipocyte-derived stem cells (ADSCs) isolated from wild-type and microRNA 140 (miR-140) knockout mice |
N/A |
expression |
MiR-140 knockout ADSCs have dramatically decreased adipogenic capabilities associated with downregulation of NEAT1 expression. Reexpression of NEAT1 in miR-140 knockout ADSCs is sufficient to restore their ability to undergo differentiation. |
26457124 |
|
prostate cancer |
RNA-seq, qPCR, ChIP etc. |
prostate cancer tissue, cell lines (LnCaP, PC3) |
up-regulated |
expression |
Among putatively ERa-regulated intergenic long non-coding RNAs (lncRNAs), we identified nuclear enriched abundant transcript 1 (NEAT1) as the most significantly overexpressed lncRNA in prostate cancer. Prostate cancer cells expressing high levels of NEAT1 were recalcitrant to androgen or AR antagonists. NEAT1 drives oncogenic growth by altering the epigenetic landscape of target gene promoters to favour transcription. |
25415230 |
Lnc2Cancer
|
|